Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The Journal of Pathology. Clinical Research|March 15, 2022
CD24 is a surrogate for 'immune-cold' phenotype in aggressive large B-cell lymphomaMorihiro Higashi, Shuji Momose, Natsuko Takayanagi, et al.
The Journal of Dermatology|December 21, 2022
Application of fluorescence in situ hybridization in distinguishing acral melanoma in situ from acral junctional melanocytic nevus on the volar skin in Japanese patientsSayaka Takai, Eiichi Arai, Naoko Shojiguchi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2023
Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell NeoplasmKana Sakamoto, Satoko Baba, Yuka Okumura, et al.
Cancers|April 13, 2024
Copy Number Analysis of 9p24.1 in Classic Hodgkin Lymphoma Arising in Immune Deficiency/DysregulationKumiko Ohsawa, Shuji Momose, Asami Nishikori, et al.
Cancer Science|December 19, 2019
Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomasYuka Tanaka, Shuji Momose, Takayuki Tabayashi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2021
Immunohistochemical staining patterns of p53 predict the mutational status of TP53 in oral epithelial dysplasiaKeisuke Sawada, Shuji Momose, Ryutaro Kawano, et al.
Respiratory Research|July 18, 2020
Possible reversibility between epithelioid and sarcomatoid types of mesothelioma is independent of ERC/mesothelin expressionMasataka Kojima, Kazunori Kajino, Shuji Momose, et al.
Human Pathology|June 25, 2010
Mesothelin (MSLN) promoter is hypomethylated in malignant mesothelioma, but its expression is not associated with methylation status of the promoterKe Tan, Kazunori Kajino, Shuji Momose, et al.
Japanese Journal of Clinical Oncology|May 8, 2020
A novel germline BMPR1A variant (c.72_73delGA) in a Japanese family with hereditary mixed polyposis syndromeYosuke Miyahara, Hideyuki Ishida, Koichi Kawabe, et al.
Pathology International|February 12, 2025
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non-Muscle Invasive Bladder CancerTakahisa Yamashita, Morihiro Higashi, Mami Yamazaki, et al.
Pageof 7